Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia.

Zhang JY, Adams AE, Ridky TW, Tao S, Khavari PA.

Cancer Res. 2007 Apr 15;67(8):3827-34.

2.

CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.

Miliani de Marval P, Lutfeali S, Jin JY, Leshin B, Selim MA, Zhang JY.

Cancer Prev Res (Phila). 2011 Jun;4(6):851-9. doi: 10.1158/1940-6207.CAPR-10-0360. Epub 2011 Apr 8.

3.

Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.

Guo Y, Wang W, Wang J, Feng J, Wang Q, Jin J, Lv M, Li X, Li Y, Ma Y, Shen B, Zhang J.

Hepatology. 2013 Jan;57(1):140-51. doi: 10.1002/hep.25978.

PMID:
22903704
4.

Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway.

Hoffmann E, Ashouri J, Wolter S, Doerrie A, Dittrich-Breiholz O, Schneider H, Wagner EF, Troppmair J, Mackman N, Kracht M.

J Biol Chem. 2008 May 2;283(18):12120-8. doi: 10.1074/jbc.M800583200. Epub 2008 Feb 15.

6.

Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.

Muniyappa H, Das KC.

Cell Signal. 2008 Apr;20(4):675-83. doi: 10.1016/j.cellsig.2007.12.003. Epub 2007 Dec 8.

7.

PKC delta mediates ionizing radiation-induced activation of c-Jun NH(2)-terminal kinase through MKK7 in human thyroid cells.

Mitsutake N, Namba H, Shklyaev SS, Tsukazaki T, Ohtsuru A, Ohba M, Kuroki T, Ayabe H, Yamashita S.

Oncogene. 2001 Feb 22;20(8):989-96.

9.

c-Jun promotes whereas JunB inhibits epidermal neoplasia.

Jin JY, Ke H, Hall RP, Zhang JY.

J Invest Dermatol. 2011 May;131(5):1149-58. doi: 10.1038/jid.2011.1. Epub 2011 Feb 3. Erratum in: J Invest Dermatol. 2011 Jun;131(6):1388.

10.

Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB.

Lee ZH, Kwack K, Kim KK, Lee SH, Kim HH.

Mol Pharmacol. 2000 Dec;58(6):1536-45.

11.

c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.

Repici M, Mare L, Colombo A, Ploia C, Sclip A, Bonny C, Nicod P, Salmona M, Borsello T.

Neuroscience. 2009 Mar 3;159(1):94-103. doi: 10.1016/j.neuroscience.2008.11.049. Epub 2008 Dec 14.

PMID:
19135136
13.

The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.

Ke H, Harris R, Coloff JL, Jin JY, Leshin B, Miliani de Marval P, Tao S, Rathmell JC, Hall RP, Zhang JY.

Cancer Res. 2010 Apr 15;70(8):3080-8. doi: 10.1158/0008-5472.CAN-09-2923. Epub 2010 Mar 30.

14.

Ras and mitogen-activated protein kinase kinase kinase-1 coregulate activator protein-1- and nuclear factor-kappaB-mediated gene expression in airway epithelial cells.

Zhou L, Tan A, Iasvovskaia S, Li J, Lin A, Hershenson MB.

Am J Respir Cell Mol Biol. 2003 Jun;28(6):762-9. Epub 2003 Jan 31.

PMID:
12600818
18.

A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway.

Yao Z, Zhou G, Wang XS, Brown A, Diener K, Gan H, Tan TH.

J Biol Chem. 1999 Jan 22;274(4):2118-25.

19.

The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway.

Chen AJ, Zhou G, Juan T, Colicos SM, Cannon JP, Cabriera-Hansen M, Meyer CF, Jurecic R, Copeland NG, Gilbert DJ, Jenkins NA, Fletcher F, Tan TH, Belmont JW.

J Biol Chem. 2002 Sep 27;277(39):36592-601. Epub 2002 Jul 23.

Supplemental Content

Support Center